Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1360412

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1360412

Global Stroke Management Market Size, Share, Growth Analysis, By Diagnosis(Imaging, blood tests), By End user (Hospitals, clinics) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Market Insights

Global Stroke Management Market size was valued at USD 37 billion in 2022 and is poised to grow from USD 15.11 billion in 2023 to USD 33.19 billion by 2030, at a CAGR of 11.9% during the forecast period (2023-2030).

The Global Stroke Management Market encompasses a range of medical solutions and interventions aimed at preventing, diagnosing, and treating strokes. This market involves pharmaceuticals, medical devices, and rehabilitation services, all designed to enhance patient outcomes and quality of life. Factors such as aging populations and increased awareness of stroke risks drive market growth. Innovations in telemedicine and neuroimaging contribute to improved diagnostic and treatment approaches. Overall, the market focuses on holistic stroke care, including acute intervention, recovery support, and long-term management for optimal patient well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of stroke management and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global stroke management market can be segmented based on diagnosis, region, and end-users. Diagnosis includes imaging, blood tests, and physical examination. End-users encompass of hospitals, clinics, and ambulatory surgical centers. Based on region, the market is segmented into North America, Latin America, Asia Pacific, Europe, and MEA.

Drivers

Factors driving the growth of the global stroke management market include the rising investment in healthcare infrastructure and the growing acceptance of innovative technologies and telemedicine options. These trends are boosting early detection and effective intervention for strokes, leading to enhanced patient results and well-being.

Restraints

Accessibility Challenges:

The growth of the worldwide stroke management market is impeded by restricted awareness in specific areas, elevated treatment expenses, and difficulties in harmonizing stroke management technologies with prevailing healthcare systems, all of which curtail its complete potential for expansion.

Market Trends

In recent times, significant progress has been observed within the global stroke management market. Advances in telemedicine and digital healthcare solutions have facilitated remote monitoring and prompt intervention. Cutting-edge neuroimaging methods like MRI and CT scans have elevated the accuracy of diagnoses. Minimally invasive surgical procedures, including endovascular thrombectomy, have brought about a revolution in the treatment of acute strokes. Furthermore, innovations in pharmaceuticals have yielded more efficient clot-dissolving medications and neuroprotective therapies. Collaborative research endeavors and public awareness initiatives have underscored the significance of early detection and risk mitigation. These collective advancements aim to enrich stroke prevention, immediate care, and prolonged rehabilitation, thereby ultimately enhancing patient outcomes and diminishing the global stroke burden.

Product Code: SQMIG35A2508

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Stroke Management Market by Diagnosis
  • Market Overview
  • Imaging
  • blood tests
  • and physical examination
  • Global Stroke Management Market by End user
  • Market Overview
  • Hospitals
  • clinics
  • and ambulatory surgical centers
  • Global Stroke Management Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Penumbra, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • GE Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Penumbra, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Balt Extrusion (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Merit Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Sirtex Medical Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!